U19AI082724
Cooperative Agreement
Overview
Grant Description
UNIVERSITY OF CHICAGO AUTOIMMUNITY CENTER OF EXCELLENCE
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Illinois
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 05/31/14 to 05/31/25 and the total obligations have increased 1961% from $351,000 to $7,232,457.
University Of Chicago was awarded
University of Chicago Autoimmunity Center of Excellence
Cooperative Agreement U19AI082724
worth $7,232,457
from the National Institute of Allergy and Infectious Diseases in June 2009 with work to be completed primarily in Illinois United States.
The grant
has a duration of 16 years and
was awarded through assistance program 93.855 Allergy and Infectious Diseases Research.
The Cooperative Agreement was awarded through grant opportunity Autoimmunity Centers of Excellence, Basic Research Program (U19 Clinical Trial Not Allowed).
Status
(Complete)
Last Modified 9/5/24
Period of Performance
6/10/09
Start Date
5/31/25
End Date
Funding Split
$7.2M
Federal Obligation
$0.0
Non-Federal Obligation
$7.2M
Total Obligated
Activity Timeline
Transaction History
Modifications to U19AI082724
Additional Detail
Award ID FAIN
U19AI082724
SAI Number
U19AI082724-679908858
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NM00 NIH NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Funding Office
75NM00 NIH NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Awardee UEI
ZUE9HKT2CLC9
Awardee CAGE
5E688
Performance District
IL-90
Senators
Richard Durbin
Tammy Duckworth
Tammy Duckworth
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Health and Human Services (075-0885) | Health research and training | Grants, subsidies, and contributions (41.0) | $3,645,632 | 100% |
Modified: 9/5/24